NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Wednesday reported third-quarter net income of $288 million.
The New York-based company said it had net income of 51 cents per share. Earnings, adjusted for non-recurring costs, came to $1.17 per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.11 per share.
The company posted revenue of $609 million in the period. Its adjusted revenue was $814 million.
Royalty Pharma expects full-year revenue in the range of $3.2 billion to $3.25 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPRX at https://www.zacks.com/ap/RPRX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
